Assessing immunoglobulin heavy chain rearrangements in pediatric CD20-positive and CD20-negative classic Hodgkin's disease

Clinical Lymphoma

Volumn 5, Issue 3, 2004, Pages 184-189

  Shiramizu, Bruce ^a,f   Perkins, Sherrie L ^b   Bergeron, Sharon ^c   Lones, Mark ^d   Kelly, Kara ^e   Weiner, Michael ^e   Cairo, Mitchell S ^e  

^a UNIVERSITY OF HAWAII   (United States)

^b ARUP LABORATORIES   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

B cell markers; Lymph node biopsy; Minimal residual disease; Polymerase chain reaction

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; PARAFFIN; PRIMER DNA;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CANCER DIAGNOSIS; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PROMOTER REGION; REED STERNBERG CELL; SEQUENCE ANALYSIS;

EID: 13644259614     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2004.n.024     Document Type: Article

References (51)

1. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26:1063-1083.
2. Harris NL. Hodgkin's lymphomas: classification, diagnosis, and grading. Semin Hematol 1999; 36:220-232.
3. Stein H, Delsol G, Pileri S, et al. Classical Hodgkin's Lymphoma In: World Health Organization Classification of Tumors, Tumors of Haematopoietic and Lymphoid Tissues. Washington, DC: IARC Press, 2001:237-254.
4. Kuppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 1994; 91:10962-10966.
5. Kuppers R, Kanzler H, Hansmann ML, et al. Single cell analysis of Hodgkin/Reed-Sternberg cells. Ann Oncol 1996; 7(suppl 4):27-30.
6. Hummel M, Ziemann K, Lammert H, et al. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 1995; 333:901-906.
7. Kanzler H, Kuppers R, Hausmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184:1495-1505.
8. Vockerodt M, Soares M, Kanzler H, et al. Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. Blood 1998; 92:2899-2907.
9. Orazi A, Jiang B, Lee CH, et al. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease. Am J Clin Pathol 1995; 104:413-418.
10. Manzanal A, Santon A, Oliva H, et al. Evaluation of clonal immunoglobulin heavy chain rearrangements in Hodgkin's disease using the polymerase chain reaction (PCR). Histopathology 1995; 27:21-25.
11. Lenormand B, Ghanem N, Tilly H, et al. Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia. Leukemia 1991; 5:928-936.
12. Rassidakis GZ, Medeiros LJ, Viviani S, et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol 2002; 20:1278-1287.
13. Bai MC, Jiwa NM, Horstman A, et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994; 174:49-55.
14. Vasef MA, Alsabeh R, Medeiros LJ, et al. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method. Am J Clin Pathol 1997; 108:54-59.
15. Schmid C, Pan L, Diss T, et al. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991; 139:701-707.
16. Pinkus GS, Said JW. Hodgkin's disease, lymphocyte predominance type, nodular - further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol 1988; 133:211-217.
17. Bangerter M, Hildebrand A, Griesshammer M. Immunophenotypic analysis of simultaneous specimens from different sites from the same patient with malignant lymphoma. Cytopathology 2001; 12:168-176.
18. Sabesan V, Cairo MS, Lones MA, et al. Assessment of minimal residual disease in childhood non-hodgkin lymphoma by polymerase chain reaction using patient-specific primers. J Pediatr Hematol Oncol 2003; 25:109-113.
19. Miglino M, Santini G, Grasso R, et al. Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation. Haematologica 2001; 86:706-714.
20. Galimberti S, Brizzi F, Mameli M, et al. An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection. Leuk Res 1999; 23:921-929.
21. Tarusawa M, Yashima A, Endo M, et al. Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele-specific oligonucleotide real-time quantitative polymerase chain reaction. Int J Hematol 2002; 75:166-173.
22. Hagemeister FB, Fesus SM, Lamki LM, et al. Role of the gallium scan in Hodgkin's disease. Cancer 1990; 65:1090-1096.
23. Kostakoglu L, Yeh SD, Portlock C, et al. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992; 33:345-350.
24. Cooper DL, Caride VJ, Zloty M, et al. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy. J Clin Oncol 1993; 11:1092-1098.
25. Gasparini MD, Balzarini L, Castellani MR, et al. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma. Cancer 1993; 72:577-582.
26. Harris EW, Rakow JI, Weiner M, et al. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease. J Nucl Med 1993; 34:1326-1330.
27. Weiner M, Leventhal B, Cantor A, et al. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study. Cancer 1991; 68:2478-2480.
28. Sharp JG, Chan WC. Detection and relevance of minimal disease in lymphomas. Cancer Metastasis Rev 1999; 18:127-142.
29. Nakamura N, Mori N, Ohshima K, et al. Epstein-Barr virus-positive Hodgkin/Reed-Sternberg-like B cell in non-hodgkin lymphoma: nucleotide sequence of the amplified immunoglobulin heavy-chain variable region gene by the single-cell polymerase chain reaction technique. Diagn Mol Pathol 2002; 11:83-89.
30. Tzankov A, Krugmann J, Fend F, et al. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: A clinicopathological study of 119 Cases. Clin Cancer Res 2003; 9:1381-1386.
31. Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 1999; 27:e12.
32. Saiki RK, Bugawan TL, Horn GT, et al. Analysis of enzymatically amplified beta-globin and HLA-DQa DNA with allele-specific oligonucleotide probes. Nature 1986; 324:163-166.
33. Brecher ML. Malignant lymphomas in children and adolescents. Semin Surg Oncol 1986; 2:147-155.
34. Hudson MM, Donaldson SS. Hodgkin's disease. Pediatr Clin North Am 1997; 44:891-906.
35. Kuppers R. Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 2002; 84:277-312.
36. Braeuninger A, Kuppers R, Strickler JG, et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 1997; 94:9337-9342.
37. Han S, Zheng B, Takahashi Y, et al. Distinctive characteristics of germinal center B cells. Semin Immunol 1997; 9:255-260.
38. Marafioti T, Hummel M, Foss HD, et al. Hodgkin and reed-stemberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95:1443-1450.
39. Papavasiliou F, Casellas R, Suh H, et al. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science 1997; 278:298-301.
40. Bellan C, Lazzi S, Zazzi M, et al. Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Diagn Mol Pathol 2002; 11:2-8.
41. Ekstrand BC, Lucas JB, Horwitz SM, et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood 2003; 101:4285-4289.
42. Rehwald U, Schulz H, Reiser M, et al. Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003; 101:420-424.
43. Keilholz U, Szelenyi H, Siehl J, et al. Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono-clonal antibody) and interleukin-2. Leuk Lymphoma 1999; 35:641-642.
44. Saxena A, Moshynska O, Kanthan R, et al. Distinct B-cell clonal bands in Helicobacter pylori gastritis with lymphoid hyperplasia. J Pathol 2000; 190:47-54.
45. Ohshima K, Suzumiya, J, Kanda M, et al. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma. Histopathology 1999; 35:539-550.
46. Onciu M, Bueso-Ramos C, Medeiros LJ, et al. Acute lymphoblastic leukemia in elderly patients the Philadelphia chromosome may not be a significant adverse prognostic factor. Am J Clin Pathol 2002; 117:716-720.
47. Riccardi A, Montecucco CM, Cresci R, et al. Cytokinetic studies on circulating neoplastic cells of Hodgkin's disease. Basic Appl Histochem 1980; 24: 109-120.
48. Malfitano A, Cazzola M, Cavalli P, et al. Morphological and cytochemical studies of circulating Hodgkin's and Reed-Sternberg cells. Basic Appl Histochem 1980; 24:101-107.
49. Wolf J, Kapp U, Bohlen H, et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 1996; 87:3418-3428.
50. Chu PG, Chen YY, Molina A, et al. Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma 2002; 43:2335-2341.
51. Rijlaarsdam U, Bakels V, van Oostveen JW, et al. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects. J Invest Dermatol 1992; 99:749-754.